| Cytokine pathways and joint inflammation in rheumatoid arthritis EHS Choy, GS Panayi New England Journal of Medicine 344 (12), 907-916, 2001 | 3326 | 2001 |
| EULAR revised recommendations for the management of fibromyalgia GJ Macfarlane, C Kronisch, LE Dean, F Atzeni, W Häuser, E Fluß, E Choy, ... Annals of the rheumatic diseases 76 (2), 318-328, 2017 | 1541 | 2017 |
| Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double‐blind, randomized, placebo‐controlled trial PJ Mease, DD Gladman, CT Ritchlin, EM Ruderman, SD Steinfeld, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 1181 | 2005 |
| EULAR evidence-based recommendations for the management of fibromyalgia syndrome SF Carville, S Arendt-Nielsen, H Bliddal, F Blotman, JC Branco, D Buskila, ... Annals of the rheumatic diseases 67 (4), 536-541, 2008 | 1127 | 2008 |
| Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis E Choy Rheumatology 51 (suppl_5), v3-v11, 2012 | 1038 | 2012 |
| 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The … JE Hoogendijk, AA Amato, BR Lecky, EH Choy, IE Lundberg, MR Rose, ... Neuromuscular Disorders 14 (5), 337-345, 2004 | 1016 | 2004 |
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study A Naranjo, T Sokka, MA Descalzo, J Calvo-Alén, K Hørslev-Petersen, ... Arthritis research & therapy 10, 1-10, 2008 | 717 | 2008 |
| Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double‐blind, placebo … EHS Choy, DA Isenberg, T Garrood, S Farrow, Y Ioannou, H Bird, ... Arthritis & Rheumatism 46 (12), 3143-3150, 2002 | 649 | 2002 |
| EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases JN Hoes, JWG Jacobs, M Boers, D Boumpas, F Buttgereit, N Caeyers, ... Annals of the rheumatic diseases 66 (12), 1560-1567, 2007 | 561 | 2007 |
| Fatigue in rheumatoid arthritis reflects pain, not disease activity LC Pollard, EH Choy, J Gonzalez, B Khoshaba, DL Scott Rheumatology 45 (7), 885-889, 2006 | 534 | 2006 |
| Interleukin-6 as a key player in systemic inflammation and joint destruction JE Fonseca, MJ Santos, H Canhao, E Choy Autoimmunity reviews 8 (7), 538-542, 2009 | 520 | 2009 |
| Translating IL-6 biology into effective treatments EH Choy, F De Benedetti, T Takeuchi, M Hashizume, MR John, ... Nature Reviews Rheumatology 16 (6), 335-345, 2020 | 512 | 2020 |
| The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review SL Westlake, AN Colebatch, J Baird, P Kiely, M Quinn, E Choy, AJK Ostor, ... Rheumatology 49 (2), 295-307, 2010 | 462 | 2010 |
| Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain KB Jensen, E Kosek, F Petzke, S Carville, P Fransson, H Marcus, ... PAIN® 144 (1-2), 95-100, 2009 | 449 | 2009 |
| Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions E Choy, N Sattar Annals of the rheumatic diseases 68 (4), 460-469, 2009 | 446 | 2009 |
| Cognitive behavioural therapies for fibromyalgia K Bernardy, P Klose, AJ Busch, EHS Choy, W Häuser Cochrane Database of Systematic Reviews, 2013 | 410 | 2013 |
| The role of interleukin 6 in the pathophysiology of rheumatoid arthritis S Srirangan, EH Choy Therapeutic advances in musculoskeletal disease 2 (5), 247-256, 2010 | 410 | 2010 |
| Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor JM Dayer, E Choy Rheumatology 49 (1), 15-24, 2010 | 398 | 2010 |
| The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis ECC Rankin, EHS Choy, D Kassimos, GH Kingsley, AM Sopwtth, ... Rheumatology 34 (4), 334-342, 1995 | 396 | 1995 |
| Adalimumab for long‐term treatment of psoriatic arthritis: forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial DD Gladman, PJ Mease, CT Ritchlin, EHS Choy, JT Sharp, PA Ory, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 390 | 2007 |
